Results 21 to 30 of about 44,285 (229)
Opportunities and challenges of circulating biomarkers in neuroblastoma [PDF]
Open Biology, 2019 Molecular analysis of nucleic acid and protein biomarkers is becoming increasingly common in paediatric oncology for diagnosis, risk stratification and molecularly targeted therapeutics. However, many current and emerging biomarkers are based on analysis
Ricky M. Trigg +2 more
doaj +1 more source
Exploration of Targeted Anti-tumor Therapy, 2022 Head and neck squamous cell carcinomas (HNSCCs) represent the most common epithelial tumors that arise from mucosa of the oral cavity, pharynx, and larynx.
Mariana Chantre-Justino +2 more
doaj +1 more source
Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma [PDF]
Journal of Liver Cancer, 2022 Advances in our knowledge of the molecular characteristics of hepatocellular carcinoma (HCC) have enabled significant progress in the detection and therapeutic prediction of HCC.
Eun-Ji Choi, Young-Joon Kim
doaj +1 more source
Cells, 2023 The treatment of locally advanced rectal cancer (LARC) requires a multimodal approach combining neoadjuvant radiotherapy or chemoradiotherapy (CRT) and surgery.
Joao Victor Machado Carvalho +3 more
doaj +1 more source
Cancer Biology & Medicine, 2016 Circulating free nucleic acids; cell free DNA and circulating micro-RNA, are found in the plasma of patients with hematologic and solid malignancies at levels higher than that of healthy individuals.
Jay Hocking +3 more
doaj +1 more source
Molecular Genetics & Genomic Medicine, 2021 Background In gestational trophoblastic disease, the prognosis is related to the genetic constitution. In some cases, taking a biopsy is contraindicated. Methods In a pregnant woman, ultrasound scanning suggested hydatidiform mole.
Lone Sunde +7 more
doaj +1 more source
Using cell-free DNA for HCC surveillance and prognosisKey points
JHEP Reports, 2021 Summary: Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer. Its incidence is rising faster than any other cancer in the United States and it remains one of the leading causes of cancer-related deaths worldwide. While advances
Nguyen H. Tran +2 more
doaj +1 more source
Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation
Advanced Biomedical Research, 2017 From the discovery of cell-free fetal (cff)-DNA in 1997 so far, many studies have been performed on various aspects of cff-nucleic acid. It is undoubted that currently, invasive prenatal diagnosis progresses to the noninvasive test. However, there are many problems.
Mahboubeh Ramezanzadeh +2 more
openaire +3 more sources
Sensors, 2023 Breast cancer is the second leading cause of cancer deaths in women worldwide; therefore, there is an increased need for the discovery, development, optimization, and quantification of diagnostic biomarkers that can improve the disease diagnosis ...
Ana-Maria Chiorcea-Paquim
doaj +1 more source
Circulating biomarkers to monitor cancer progression and treatment
Computational and Structural Biotechnology Journal, 2016 Tumor heterogeneity is a major challenge and the root cause of resistance to treatment. Still, the standard diagnostic approach relies on the analysis of a single tumor sample from a local or metastatic site that is obtained at a given time point. Due to
Suthee Rapisuwon +2 more
doaj +1 more source